Nav1.7 inhibitor |
| Catalog No.GC36697 |
Nav1.7 inhibitor (compound II), a sulfonamide, is a potent Nav1.7 inhibitor.
Products are for research use only. Not for human use. We do not sell to patients.
Cas No.: 1355631-24-1
Sample solution is provided at 25 µL, 10mM.
Product has been cited by 1 publications
Product Documents
Quality Control & SDS
- View current batch:
- Purity: >99.50%
- COA (Certificate Of Analysis)
- SDS (Safety Data Sheet)
- Datasheet
Nav1.7 inhibitor is a potent Nav1.7 inhibitor.IC50 value:Target: Nav1.7Preparation of sulfonamide derivatives as Nav1.7 inhibitorsBy Brown, Alan Daniel; Rawson, David James; Storer, Robert Ian; Swain, Nigel Alan From PCT Int. Appl. (2012), WO 2012007868 A2 20120119.
[1]. Preparation of sulfonamide derivatives as Nav1.7 inhibitors. Patent WO 2012007868 A2 20120119
| Cas No. | 1355631-24-1 | SDF | |
| Canonical SMILES | O=C(NS(=O)(C)=O)C1=CC(Cl)=C(COC2=CC=C(Cl)C(Cl)=C2)C=C1F | ||
| Formula | C15H11Cl3FNO4S | M.Wt | 426.67 |
| Solubility | DMSO: ≥ 100 mg/mL (234.37 mM); Water: < 0.1 mg/mL (insoluble) | Storage | Store at -20°C |
| General tips | Please select the appropriate solvent to prepare the stock solution according to the
solubility of the product in different solvents; once the solution is prepared, please store it in
separate packages to avoid product failure caused by repeated freezing and thawing.Storage method
and period of the stock solution: When stored at -80°C, please use it within 6 months; when stored
at -20°C, please use it within 1 month. To increase solubility, heat the tube to 37°C and then oscillate in an ultrasonic bath for some time. |
||
| Shipping Condition | Evaluation sample solution: shipped with blue ice. All other sizes available: with RT, or with Blue Ice upon request. | ||
Complete Stock Solution Preparation Table
| Prepare stock solution | |||
|
1 mg | 5 mg | 10 mg |
| 1 mM | 2.3437 mL | 11.7187 mL | 23.4373 mL |
| 5 mM | 0.4687 mL | 2.3437 mL | 4.6875 mL |
| 10 mM | 0.2344 mL | 1.1719 mL | 2.3437 mL |
In vivo Formulation Calculator (Clear solution)
Step 1: Enter information below (Recommended: An additional animal making an allowance for loss during the experiment)
g
μL
Step 2: Enter the in vivo formulation (This is only the calculator, not formulation. Please contact us first if there is no in vivo formulation at the solubility Section.)
Calculation results:
Working concentration: mg/ml;
Method for preparing DMSO master liquid: mg drug pre-dissolved in μL DMSO ( Master liquid concentration mg/mL, Please contact us first if the concentration exceeds the DMSO solubility of the batch of drug. )
Method for preparing in vivo formulation: Take μL DMSO master liquid, next addμL PEG300, mix and clarify, next addμL Tween 80, mix and clarify, next add μL ddH2O, mix and clarify.
Method for preparing in vivo formulation: Take μL DMSO master liquid, next add μL Corn oil, mix and clarify.
Note: 1. Please make sure the liquid is clear before adding the next solvent.
2. Be sure to add the solvent(s) in order. You must ensure that the solution obtained, in the previous addition, is a clear solution before proceeding to add the next solvent. Physical methods such as vortex, ultrasound or hot water bath can be used to aid dissolving.
3. All of the above co-solvents are available for purchase on the GlpBio website.
Related Products
- GC33577 7-Aminoactinomycin D (7-AAD)
- GC11559 Anisomycin
- GC16948 Valinomycin
- GC17282 TCS JNK 6o
- GC16291 Phentolamine Mesylate
- GC19331 SHP099 hydrochloride
- GC42661 A-54556B
- GC50097 A12B4C3
- GC10448 Bivalirudin Trifluoroacetate
- GC38334 SPDMV
- GC45552 Pyrenophorol
- GC45137 Valproic Acid Acyl-D-Glucuronide
- GC14417 NNC 55-0396
- GC16617 IM-12
- GC18285 Aflatoxin M2
- GC13285 Galiellalactone
- GC38031 CORM-3
Reviews
Average Rating: 5 ★★★★★ (Based on Reviews and 31 reference(s) in Google Scholar.)
GLPBIO products are for RESEARCH USE ONLY. Please make sure your review or question is research based.
Required fields are marked with *